BIMI International Medical is a holding company. Through its subsidiaries, Co. is engaged in health care industry. Co. operates in four reportable segments: wholesale medical devices, which distributes medical devices, including medical consumables; wholesale pharmaceuticals, which includes supplying prescription and over-the-counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items; medical services, which includes the hospitals acquired; and retail pharmacies, which sells prescription and OTC medicines, TCM, healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The BIMI stock yearly return is shown above.
The yearly return on the BIMI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BIMI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|